Skip to main content
SpringerLink
Log in

Label comprehension of potential over-the-counter naloxone

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 1. Note that some people may have symptoms when they wake up, such as shaking, sweating, having nausea, or feeling angry. 2. Note that it is safe to keep giving doses. 3. Give another dose if the person becomes very sleepy again. 4. Make sure that the "call 911" step is completed in the appropriate order relative to the other steps. 5. Perform steps 1-5; check for a suspected overdose, give the first dose, call 911 immediately, repeat doses every few minutes, stay with the person until the ambulance arrives.

Reference

  • Cohen BR, et al. FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone. New England Journal of Medicine 382: 2129-2136, No. 22, 28 May 2020. Available from: URL: http://doi.org/10.1056/NEJMsa1912403

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Label comprehension of potential over-the-counter naloxone. Reactions Weekly 1808, 10 (2020). https://doi.org/10.1007/s40278-020-79487-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-79487-8

Search

Navigation